Actively Recruiting
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
Led by Petrovsky National Research Centre of Surgery · Updated on 2026-01-29
50
Participants Needed
1
Research Sites
159 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.
CONDITIONS
Official Title
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of thoracic aorta aneurysm or dissection
You will not qualify if you...
- Blood sample hemolysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Petrovsky Research National Centre of Surgery (Petrovsky NRCS)
Moscow, Moscow, Russia, 119991
Actively Recruiting
Research Team
A
Artem Gubko, Ph.D.
CONTACT
B
Boris Akselrod, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here